Literature DB >> 26294649

Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration.

M E Adin1, L Kleinberg2, D Vaidya3, E Zan4, S Mirbagheri4, D M Yousem4.   

Abstract

BACKGROUND AND
PURPOSE: A hyperintense appearance of the dentate nucleus on T1-weighted MR images has been related to various clinical conditions, but the etiology remains indeterminate. We aimed to investigate the possible associations between a hyperintense appearance of the dentate nucleus on T1-weighted MR images in patients exposed to radiation and factors including, but not limited to, the cumulative number of contrast-enhanced MR images, amount of gadolinium administration, dosage of ionizing radiation, and patient demographics.
MATERIALS AND METHODS: The medical records of 706 consecutive patients who were treated with brain irradiation at The Johns Hopkins Medical Institutions between 1995 and 2010 were blindly reviewed by 2 readers.
RESULTS: One hundred eighty-four subjects were included for dentate nuclei analysis. Among the 184 subjects who cumulatively underwent 2677 MR imaging studies following intravenous gadolinium administration, 103 patients had hyperintense dentate nuclei on precontrast T1-weighted MR images. The average number of gadolinium-enhanced MR imaging studies performed in the group with normal dentate nuclei was significantly lower than that of the group with hyperintense dentate nuclei. The average follow-up time was 62.5 months. No significant difference was observed between hyperintense and normal dentate nuclei groups in terms of exposed radiation dose, serum creatinine and calcium/phosphate levels, patient demographics, history of chemotherapy, and strength of the scanner. No dentate nuclei abnormalities were found on the corresponding CT scans of patients with hyperintense dentate nuclei (n = 44). No dentate nuclei abnormalities were found in 53 healthy volunteers.
CONCLUSIONS: Repeat performance of gadolinium-enhanced studies likely contributes to a long-standing hyperintense appearance of dentate nuclei on precontrast T1-weighted-MR images.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26294649      PMCID: PMC4878403          DOI: 10.3174/ajnr.A4378

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

2.  Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.

Authors:  D E Ray; J B Cavanagh; C C Nolan; S C Williams
Journal:  AJNR Am J Neuroradiol       Date:  1996-02       Impact factor: 3.825

3.  High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.

Authors:  S A Mirowitz; K Sartor; M Gado
Journal:  AJR Am J Roentgenol       Date:  1990-02       Impact factor: 3.959

4.  Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.

Authors:  Yuri Errante; Vincenzo Cirimele; Carlo Augusto Mallio; Vincenzo Di Lazzaro; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi
Journal:  Invest Radiol       Date:  2014-10       Impact factor: 6.016

5.  Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images.

Authors:  E Inoue; S Hori; Y Narumi; M Fujita; K Kuriyama; T Kadota; C Kuroda
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

6.  Radiation-induced brain calcification: paradoxical high signal intensity in T1-weighted MR images.

Authors:  S Suzuki; S Nishio; K Takata; T Morioka; M Fukui
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

Review 7.  Radiation-induced cavernomas of the brain.

Authors:  Rajan Jain; Patricia L Robertson; Dheeraj Gandhi; Sachin K Gujar; Karin M Muraszko; Stephen Gebarski
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

Review 8.  Radiation injury of the brain.

Authors:  P E Valk; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  1991-01       Impact factor: 3.825

9.  CT evidence of grey matter calcification secondary to radiation therapy.

Authors:  K F Lee; J H Suh
Journal:  Comput Tomogr       Date:  1977

10.  Non-heme mechanisms for T1 shortening: pathologic, CT, and MR elucidation.

Authors:  O B Boyko; P C Burger; J D Shelburne; P Ingram
Journal:  AJNR Am J Neuroradiol       Date:  1992 Sep-Oct       Impact factor: 3.825

View more
  46 in total

1.  Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.

Authors:  Sohi Bae; Ho-Joon Lee; Kyunghwa Han; Yae-Won Park; Yoon Seong Choi; Sung Soo Ahn; Jinna Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

2.  Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.

Authors:  Takao Koiso; Masaaki Yamamoto; Shinya Watanabe; Bierta E Barfod
Journal:  Neuroradiol J       Date:  2019-03-29

Review 3.  Distribution and chemical forms of gadolinium in the brain: a review.

Authors:  Tomonori Kanda; Yudai Nakai; Akifumi Hagiwara; Hiroshi Oba; Keiko Toyoda; Shigeru Furui
Journal:  Br J Radiol       Date:  2017-09-28       Impact factor: 3.039

Review 4.  Gadolinium retention in the body: what we know and what we can do.

Authors:  Enrico Tedeschi; Ferdinando Caranci; Flavio Giordano; Valentina Angelini; Sirio Cocozza; Arturo Brunetti
Journal:  Radiol Med       Date:  2017-03-30       Impact factor: 3.469

5.  Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.

Authors:  Aida Kiviniemi; Maria Gardberg; Paul Ek; Janek Frantzén; Johan Bobacka; Heikki Minn
Journal:  Neuroradiology       Date:  2019-02-02       Impact factor: 2.804

6.  Follow-Up MRI for Small Brain AVMs Treated by Radiosurgery: Is Gadolinium Really Necessary?

Authors:  X Leclerc; O Guillaud; N Reyns; J Hodel; O Outteryck; F Bala; N Bricout; M Bretzner; N Ramdane; J-P Pruvo; L Hacein-Bey; G Kuchcinski
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-06       Impact factor: 3.825

7.  Reply to Lancelot et al.: 'Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children'.

Authors:  Maria Camilla Rossi Espagnet; Paolo Tomà; Antonio Napolitano
Journal:  Pediatr Radiol       Date:  2017-09-06

Review 8.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 9.  Gadolinium-based contrast agents in children.

Authors:  Michael N Rozenfeld; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2018-08-04

10.  Dentate nucleus T1 hyperintensity: is it always gadolinium all that glitters?

Authors:  Luca Pasquini; Maria Camilla Rossi Espagnet; Antonio Napolitano; Daniela Longo; Alice Bertaina; Emiliano Visconti; Paolo Tomà
Journal:  Radiol Med       Date:  2018-01-27       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.